Defects of β2-adrenergic signal transduction in chronic lymphocytic leukaemia: Relationship to disease progression

European Journal of Clinical Investigation

Volumn 27, Issue 2, 1997, Pages 121-127

  Kamp, T ^a,b   Liebl, B ^c   Haen, E ^c   Emmerich, B ^b   Hallek, M ^b  

^a I Medizinische Abteilung   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

adenylyl cyclase; adrenergic receptor; chronic lymphocytic leukaemia; forskolin; isoprenaline

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; CHOLERA TOXIN; CYANOPINDOLOL I 125; CYCLIC AMP; FORSKOLIN; ISOPRENALINE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031046827     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.700623.x     Document Type: Article

References (45)

1. Gilman AG. Proteins and dual control ot the adenylate cyclase. Cell 1984;36:577-9.
2. Brodde OE, Engel G, Hoyer D, Bock KD, Weber F. The β-adrenergic receptor in human lymphocytes: subclassification by the use of a new radioligand (±)-[125]Iodocyanopindolol. Life Sci 1981;29:2189-98.
3. Tang WJ, Gilman AG. Adenylyl cyclases. Cell 1992;70:869-72.
4. Olsson IL, Breitmann TR, Gallo RC, Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic 3′:5′-adenosine monophospate-inducing agents and a T-lymphocyte differentiation factor. Cancer Res 1982;42:3928-33.
5. MacManus JP, Whitfield JH, Youdale T. Stimulation by epinephrine of adenyl cyclase activity, cyclic AMP formation, DNA synthesis and cell proliferation in populations of rat thymocytic lymphocytes. J Biol Cell Phys 1970;77:103-16.
6. Schreiner GF, Unanaue ER. The modulation of spontaneous and anti Ig stimulated motility of lymphocytes by cyclic nucleotides and adrenergic and cholinergic agents. J Immunol 1975;114:802-5.
7. Braun W, Rega MJ. Adenyl cyclase-stimulating catecholamines as modifiers of antibody formation. Immunol Commun 1972; 1:523-32.
8. Watson J. The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J Exp Med 1975;141:97-111.
9. Coffey RG, Hadden JW. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation. Fed Proc 1985;44:112-7.
10. Seuwen K, Pouysssegur J. G protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res 1992;58:75-94.
11. Perrachi M, Lombardi L, Toschi V et al. Plasma and urine cyclic nucleotide levels in patients with neoplastic diseases. Cancer 1984;54:3028.
12. Ben-Zvi A, Russel A, Sheneyour A, Trainin N. Cyclic AMP in human lymphocytes. Levels in akute leukemia and infectious mononucleosis. Eur J Cancer 1979;15:615-7.
13. Monahan TM, Marchand NW, Fritz RR, Abell CW. Cyclic adenosine 3′:5′-monophosphate levels and activities of related enzymes in normal and leukemic lymphocytes. Cancer Res 1975;35:2540-7.
14. Hallek M, Kamp T, Haen E, Göhly U, Emmerich B, Remien J. Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells. Biochem Pharmacol 1991;42:1329-34.
15. Bidart JM, Motte P, Bohoun C, Bellet D. Lymphocytes aminergic binding in chronic lymphocytic leukemia. Leukemia Res 1981; 5(6):443-6.
16. Sheppard JR, Gormus R, Moldow CF. Catecholamine hormone receptors are reduced on chronic lymphocytic leukemic lymphocytes. Nature 1977;269:693-5.
17. Paietta E, Schwarzmeier JD. Differences in β-adrenergic receptor density and adenylate cyclase activity between normal and leukemic lymphocytes. Eur J Clin Invest 1983;13:339-46.
18. Haen E, Liebl B, Lederer T, Pliska V. Revised radioreceptor assay for β-adrenoceptors expressed on peripheral mononuclear leukocytes. Pharmacol Toxicol 1987;61:265-70.
19. Binet JL, Catovsky D, Chandra P. Chronic lymphocytic leukemia: proposal for a revised staging system. Br J Haematol 1981;48: 365-7.
20. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968;21(Suppl. 97):77-89.
21. Haen E, Langenmayer I, Pangerl A, Liebl B, Remien J. Circannual variation in the expression of β2-adrenoceptors on human peripheral mononuclear leukocytes. Klin Wschr 1988;66:579-82.
22. Anhäupl T, Liebl B, Remien J. Kinetic and equilibrium studies of (-)125Iodocyanopindolol binding to β-adrenoceptors on human lymphocytes: evidence for the existence of two classes of binding sites. J Receptor Res 1988;8(1-4):47-57.
23. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-72.
24. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974;58541-8.
25. Anderson WB, Gallo R, Pastan I. Adenylate cyclase activity in fibroblasts transformed by Kirsten or Moloney sarcoma viruses. J Biol Chem 1974;249:7041-8.
26. Friedman DL. Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev 1976;56(4):652-708.
27. Hsie A, Jones C, Puck T. Further changes in differentiation state accompanying the conversion of chinese hamster cells to fibroblastic form by dibutyryl adenosine cyclic 3′:5′-monophosphate and hormones. Proc Natl Acad Sci USA 1971;68:1648.
28. Krawietz W, Werdan K, Schober M, Erdmann E, Rindfleisch GE, Hannig K. Different numbers of β-receptors in human lymphocyte subpopulations. Biochem Pharmacol 1982;31:133-6.
29. Landmann RMA, Bürgisser E, Wesp M, Bühler FR. Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. J Receptor Res 1984;4:37-50.
30. Okamoto T, Murayama Y, Hayashi Y, Inagaki M, Ogata E, Nishimoto I. Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 1991;67:723-30.
31. Levitzky A. Coupling of β-adrenoceptors to adenylate cyclase and the role of the GTP binding protein in signal transduction. In: Perspectives on Receptor Classiciation. Little Rock: Alan R. Liss, 1987;87-94.
32. Su HL, Malbon CC, Wang HY. Increased expression of Gi alpha 2 in mouse embryo stem cells promotes terminal differentiation to adipocytes. Am J Physiol 1993;265(Pt 1):C1729-35.
33. Lefkowitz RJ. G protein-coupled receptor kinases. Cell 1993; 74:409-12.
34. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Ann Rev Neurosci 1992;15:87-114.
35. Schimmer BP, Tsao J, Borenstein R, Endrenyi L. Forskolin resistant Y1 mutants harbor defects associated with the guanyl nucleotide-binding regulatory protein, Gs. J Biol Chem 1987;262:15521-6.
36. Zeuzem S, Schulz I, Caspary WF. GTP-bindende Proteine in der Pathophysiologie innerer Erkrankungen. Dt Ärztebl 1992;89(33):A 2768-74.
37. Mitchell J, Northup JK, Schimmer BP. Defective guanyl nucleotide binding protein βγ subunits in a forskolin-resistant mutant of the Y1 adrenocortical cell line. Proc Natl Acad Sci USA 1992;89: 8933-7.
38. Haga T, Ross EM, Anderson HJ, Gilman AG. Adenylate cyclase permanently uncoupled from hormone receptors in a novel variant of S49 mouse lymphoma cells. Proc Natl Acad Sci USA 1977; 74:2016-20.
39. George ST, Malbon CC. β-adrenergic receptor of S49 mouse lymphoma cells: purification and properties. Ann NY Acad Sci 1987;84:99-101.
40. Bourne HR, Beiderman B, Steinberg F, Brothers VM. Three adenylate cyclase phenotypes in S49 lymphoma cells produced by mutations of one gene. Mol Pharmacol 1982;22:205-10.
41. Clapham DE. Mutations in G protein-linked receptors: novel insights on disease. Cell 1993;75:1237-9.
42. Raymond JR. Hereditary and acquired defects in signaling through the hormone-receptor-G protein complex. Am J Physiol 1994; 266:F163-74.
43. Spiegel AM, Weinstein LS, Shenker A. Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest 1993;92:1119-25.
44. Botilsrud M, Kvam L, Blomhoff HK, Norum K, Blomhoff R. Cytotoxic effect of TNF-alpha and abnormal regulation of cAMP in the retinoid resistant cell line U937/GTB. Anticancer Res 1990;10:433-6.
45. Inhorn L, Fleming JW, Klingberg D, Gabig T, Boswell HS. Restoration of adenylate cyclase responsiveness in murine myeloid leukemia permits inhibition of proliferation by hormone. Butyrate augments catalytic activity of adenylate cyclase. Blood 1988; 71:1003-11.